Research ArticleCancer

Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade

See allHide authors and affiliations

Science Translational Medicine  09 Sep 2020:
Vol. 12, Issue 560, eaax2282
DOI: 10.1126/scitranslmed.aax2282

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article